Skip to main content
Nectar Lifesciences Limited logo

Nectar Lifesciences Limited — Investor Relations & Filings

Ticker · NECLIFE ISIN · INE023H01027 LEI · 335800RY4LGC64KN9C05 BSE.NS Manufacturing
Open in API
Filings indexed 538 across all filing types
Latest filing 2025-10-17 Regulatory Filings
Country IN India
Listing BSE.NS NECLIFE

About Nectar Lifesciences Limited

https://www.neclife.com/

Nectar Lifesciences Limited is a pharmaceutical organization specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company maintains a significant focus on the cephalosporin segment, producing a wide range of oral and sterile products including Cefixime, Cefuroxime Axetil, and Ceftriaxone. Its operations encompass a fully integrated business model supported by large-scale manufacturing facilities that adhere to international regulatory standards such as USFDA and EUGMP. In addition to its core antibiotic portfolio, the company produces menthol and phytochemicals. Nectar Lifesciences serves a global clientele through contract manufacturing and development services, leveraging its research and development capabilities to provide high-quality therapeutic solutions across various international markets.

Recent filings

Filing Released Lang Actions
General Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges referencing Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The content discusses an update on the extension of the expected completion date for a slump sale transaction. It references prior disclosures and meeting notices related to the transaction but does not contain financial statements or detailed financial data. The document is short (2269 characters) and serves as an announcement/update about a corporate transaction rather than a full report or detailed filing. It is not a full merger filing (MA) or takeover bid but an update on a material event related to a business sale. This fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and disclosures that do not fit other specific categories.
2025-10-17 English
Shareholders meeting
AGM Information Classification · 100% confidence The document is titled as the "Minutes of 30th Annual General Meeting (AGM)" of Nectar Lifesciences Limited held on September 29, 2025. It includes detailed descriptions of the meeting proceedings, attendance, resolutions passed, voting results, and references to the financial statements and reports considered during the AGM. The document is a formal record of the AGM proceedings rather than the financial statements or reports themselves. It also includes the announcement of voting results for resolutions passed at the AGM. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including minutes and voting results. The document is lengthy (15,000 characters) and contains substantive content related to the AGM, not just an announcement of a report publication or a brief notice. Therefore, the appropriate classification is AGM Information (AGM-R).
2025-10-09 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 92% confidence The document is a regulatory compliance certificate under SEBI’s Depositories and Participants Regulations (Regulation 74(5)), submitted to stock exchanges. It does not contain financial statements or detailed financial data, nor is it announcing dividends, board changes, or share issues. This is a routine regulatory filing submitting a compliance certificate. Falls under the general Regulatory Filings category (RNS).
2025-10-03 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 93% confidence The document is a filing to stock exchanges under SEBI LODR regulations providing the voting results of the 30th Annual General Meeting along with the Scrutinizer’s Report. It lists resolutions passed, vote counts, and includes annexures detailing the consolidated scrutinizer report. There is no substantive financial data analysis or presentation; it solely declares AGM voting outcomes. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement.
2025-09-29 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is titled as "Proceedings of 30th Annual General Meeting (AGM)" and details the events and discussions that took place during the AGM held on September 29, 2025. It includes information about the directors present, auditors, voting procedures, resolutions passed, and closing remarks by the chairman. The content is a summary of the AGM proceedings rather than the full AGM presentation materials or the voting results alone. It is not a full annual report, audit report, or earnings release. The document length is 8577 characters, which is substantial and contains detailed meeting proceedings. Therefore, the document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including proceedings summaries.
2025-09-29 English
Trading Window
Regulatory Filings Classification · 100% confidence The document is a notice regarding the closure of the trading window for designated persons and their immediate relatives in compliance with SEBI regulations. It informs about the trading restrictions around the declaration of financial results for the period ended September 30, 2025. The document is a regulatory announcement related to insider trading compliance and trading restrictions, not a financial report, earnings release, or any detailed financial disclosure. It is short (1983 characters) and serves as a regulatory compliance notification. Therefore, it fits best under Regulatory Filings (RNS).
2025-09-25 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.